FluoroType CT

FluoroType CT

Fast, reliable and cost-efficient detection of C. trachomatis

Your molecular genetic test system for the detection of Chlamydia trachomatis from patient specimens

FluoroType® CT is based on an innovative fluorescence-based technology enabling the direct detection of Chlamydia trachomatis from cervical swabs, urine and ejaculate.

  • Description


Your benefits with FluoroType® CT

  • High sensitivity and specificity: The simultaneous detection of two highly conserved target sequences, in the MOMP gene and cryptic plasmid, allows for sensitive and reliable results.
  • Cost-efficient: As a nucleic acid amplification test (NAT) the FluoroType® CT is a reliable, cost-effective screening tool for C. trachomatis.
  • Reliable: The internal control (IC) ensures a successful extraction and also serves as inhibition control for the amplification. Valid results are therefore guaranteed.
  • Compatible with NG test: If necessary, DNA isolated with the FluoroLyse kit can be used for the FluoroType® NG and examined for the presence of Neisseria gonorrhoeae. Consequently, you don’t have to request any further patient specimen or repeat the DNA extraction procedure.
  • User-friendly: A ready-to-use amplification mix already including the Taq polymerase is provided with each kit. Amplification and detection run fully automated in a closed system. The evaluation is done by the test-specific software.
  • CE0483-marked IVD: No need for elaborate validation studies.

At a glance
Molecular genetic test system for direct detection of Chlamydia trachomatis from patient specimen

Starting material:
Cervical swabs, urine, ejaculate